Genflow Biosciences 4/30/2025 Earnings Report

Genflow Biosciences EPS Results

• Actual EPS: -GBX 0.47
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Genflow Biosciences Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Genflow Biosciences Announcement Details

• Date: 4/30/2025
• Time: N/A
• Conference Call Date: N/A
• Conference Call Time: N/A

Genflow Biosciences (LON:GENF) is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.